MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge
Abstract Rett syndrome is a severe and progressive neurological disorder linked to mutations in the MeCP2 gene. It has been suggested that immune alterations may play an active role in the generation and/or maintenance of RTT phenotypes. However, there is no clear consensus about which pathways are...
Guardado en:
Autores principales: | M. I. Zalosnik, M. C. Fabio, M. L. Bertoldi, C. N. Castañares, A. L. Degano |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e167572fef6d48aba42e87b6f968b708 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome
por: Derek J. C. Tai, et al.
Publicado: (2016) -
Sequence features accurately predict genome-wide MeCP2 binding in vivo
por: H. Tomas Rube, et al.
Publicado: (2016) -
Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment
por: Justin J. -L. Wong, et al.
Publicado: (2017) -
MeCP2 regulates gene expression through recognition of H3K27me3
por: Wooje Lee, et al.
Publicado: (2020) -
Rett syndrome linked to defects in forming the MeCP2/Rbfox/LASR complex in mouse models
por: Yan Jiang, et al.
Publicado: (2021)